DTx Podcast with Eugene Borukhovich

In this episode I speak with Seth Feuerstein, Founder and CEO of Oui therapeutics, a digital therapeutic company that recently came out of stealth. In their own words: Oui is purpose built to tackle suicide and other challenging health care problems.In this episode, we cover: The background and funding journey to creating Oui What are the existing options for suicide prevention? What is the patient experience on a digital therapeutic for suicide? Approaching to the FDA with a DTx for suicide prevention Commercializing DTx and scaling the company Guest Links and Resources:Connect with Seth Feuerstein on LinkedIn Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Nate Beyor, managing director and partner of BCG healthcare. We dive into many topics around digital therapeutics and get a bird's eye view across BCG's customer base.In this episode, we cover: New company creation: large company spin-outs vs entrepreneurs  What it takes to build a team that can take a digital therapeutic to market Why build rather than buy a new DTx Approaching medical pharma clients vs approaching smaller DTx companies Go to market strategy and value creation: Standalone vs Drug+ Embedding clinical decision support into workflows Guest Links and Resources: Connect with Nate Beyor on: LinkedIn Visit: www.bcg.com/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Meg Barron, Vice President of Digital Health Strategy at the American Medical Association, which represents the voices of over ¼ million physicians and is the largest and only national association that convenes 190+ state and specialty medical societies and other critical stakeholdersIn this episode, we cover: AMA’s position on digital health- how do we help to make technology an asset to physicians and patients  How the AMA Physician Innovation Network is connecting healthtech companies and physicians Patient experience on digital therapies and addressing physician burnout Expectations and reimbursement of the physician and the return on health value framework And much more!Guest Links and Resources: Connect with Meg Barron on LinkedIn Visit www.ama-assn.org Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Today, I speak with Mark Bini, Vice President of Pharmacy Care Solutions at Evernorth - Cigna’s health services arm which spearheaded a digital health formulary which includes companies such as Omada, QuitGenious and Hinge Health In this episode, we cover: The history and evolution of Evernorth How Evernorth works with it's parent Cigna colleagues What it takes for a DTx to be part of the formulary The patient experience using DTx How Evernorth set the pricing with each DTx partner and how to “activate” upstream with clients When will Evernorth include PDT's? and much more!Guest Links and Resources: Connect with Mark Bini on LinkedIn Visit www.evernorth.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode we hear from Steve Driver, the Medical Director of Digital Therapeutics at one of the largest health systems in the US, Advocate Aurora Health. I have been itching to get a view from a health system perspective on this show since season one. As a practicing cardiologist, it is always great to hear from somebody who is practicing this in the front lines. We cover:  The expectations of the role as a Medical Director of Digital Therapeutics for a large health system. The level of evidence required for adoption in a health system The future of the patient journey using DTx DTx standalone versus drug+ The role of the pharmacists in dispensing digital therapeutics Guest Links and Resources: Connect with Steve Driver on LinkedIn | Twitter Visit www.advocateaurorahealth.org/ Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode we jumped right into the drug+ discussion with Pamela Stahl, Chief Commercial Officer at Sidekick Health.In their own words Sidekick health is all about “Gamified digital therapeutics built on science, rooted in behavioral economics, and scalable across multiple therapeutic areas.”In this episode, we cover: The origin of Sidekick Health and what led Tryggvi to start the company The funding journey from being a young company in Iceland to today Patient and health consumer experience Combining clinical evidence with gamification The complexities of clinical trials with pharma clients And much more! Guest Links and Resources: Connect with Pamela Stahl on LinkedIn Visit sidekickhealth.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode we jump back into interviewing some of the early trailblazers and speak with Dennis Wall, Founder of Cognoa.In their owns words, “Cognoa is a pediatric behavioral health company developing digital diagnostic and therapeutic products with the goals of enabling earlier and more equitable access to care and improving the lives and outcomes of children and families living with behavioral health conditions, starting with autism.”In this episode, we cover: The founding story and funding journey of Cognoa Patient journey for children using Canvas Dx for autism spectrum disorder (ASD) diagnostic and therapeutics How the diagnosis and treatment interplay works in the context of a autism digital therapeutic Evidence generation journey Working flexibly with pediatricians and doctors for distribution The collaborative care model alongside DTx Guest Links and Resources: Connect with Dennis Wall on LinkedIn | Twitter Visit: cognoa.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we take a break from interviewing entrepreneurs and switch gears to get into a head of one of the investors in the industry, Justin Norden.Justin is a Partner at GSR Ventures where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health.In this episode, we cover: The Healthcare Thesis at GSR Ventures Virtual Reality (VR) Digital Therapeutics Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx What it would take to scale existing Prescription Digital Therapeutics The Role Of Health Coaching alongside AI automation The Drivers of Success Going Forward for the Digital Therapeutics Market Guest Links and Resources: Connect with Justin Norden on LinkedIn | Twitter Visit https://gsrventuresglobal.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Gut-directed hypnotherapy has an ability to retrain both nervous systems to work together to communicate better, giving the central nervous system the ability to downregulate the hyper vigilant signals that are being sent up from the enteric nervous system.Despite there being over 20 different randomized controlled trials showing that gut directed hypnotherapy has a positive impact on all of the symptoms of for functional GI disorders, experts still don't really know exactly why it worksTo learn more about the future of gut-directed hypnotherapy and the role DTx can play, I went straight to Tim Rudolphi, CEO of metaMe Health.metaMe, in their own words “believe the best medicine may not be medicine at all. By developing innovative prescription digital therapeutics (PDTs) to combat many common chronic conditions, they are putting the power to heal right in the hands of their patients.” starting with gut health.In this episode, we cover: The founding story of metaMe Health The scientific thesis behind gut-directed hypnotherapy metaMe’s business hypothesis in action: the process of selling prescription digital therapeutic to a doctor Commercialization of Prescription Digital Therapeutics Making space for DTx alongside health coaching Guest Links and Resources: Connect with Tim Rudolphi on LinkedIn | Twitter Visit: metamehealth.com Episode Mentions: Danny Bern Brian Dolan The Lancet Mahana Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Biofourmis is not your typical standalone DTx company! On the heels of a $300M round, Biofourmis has evolved to a full data driven healthcare services organization with a strong foundation of digital therapies driving care decisions.To learn more about their work and plans for the future, I went straight to Kuldeep Singh Rajput, founder and CEO of Biofourmis.Biofourmis, in their own words, “utilizes machine learning, integrated technology and an FDA-cleared analytics engine to streamline connections between patients and care teams, leading to better outcomes for all.”In this episode we cover: The path from creation to funding Digital therapeutic companies evolving into virtual care platforms Kuldeep’s business hypothesis to entrepreneurial journey Being device agnostic: build vs buy Patient adoption and utilization And much more! Guest Links and Resources: Connect with Kuldeep Singh on LinkedIn | Twitter Visit biofourmis.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus HealthFollow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | Instagram